Skip to content

Analysis of the standard rate of pharmacokinetics/drug efficacy of antibacterial drugs in patients in the intensive care unit: a prospective, observational, cohort study

Analysis of the standard rate of pharmacokinetics/drug efficacy of antibacterial drugs in patients in the intensive care unit: a prospective, observational, cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119216
Enrollment
Unknown
Registered
2026-02-24
Start date
2025-10-29
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severely infected

Interventions

The group with normal liver function and the group with normal kidney function:None
Renal insufficiency combined with CRRT in the group with normal liver function:None
In the group with normal liver function, renal insufficiency is not combined with CRRT group.:None
The group with normal liver function and the group with hyperrenal disfunction:None
The group of liver insufficiency and the group with normal kidney function:None
Renal insufficiency combined with CRRT group in the liver failure group:None
In the liver failure group, renal insufficiency is not combined with CRRT group.:None
Hypernephrophy group in the hepatic insufficiency group:None

Sponsors

Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The age of hospitalisation in ICU is >=18 years old; 2. It is expected to stay in the ICU for at least 7 days; 3. Receive antibacterial drug treatment (oral or intravenous) to be studied in the 14th day before entering the ICU; 4. Patients who need to continue the above drugs for 2-14 days due to presumed or confirmed infection; 5. Patients who already have blood drug concentration data of antibacterial drugs; 6. Participate voluntarily and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant and/or lactating patients; 2. Die within 3 days after being discharged from the ICU or entering the group; 3. Drug taboos; 4. Oppose to participate in research. The patient's complications and kidney clearance rate do not constitute the exclusion criteria.

Design outcomes

Primary

MeasureTime frame
Antibacterial drug PK/PD standard rate;Clinical outcome;30-day all-cause mortality rate;

Secondary

MeasureTime frame
Effectiveness evaluation (body temperature, oxygenation index, inflammation index, etc.);Types of adverse reactions;Cause and effect of adverse reactions;Grading of adverse reactions;

Countries

China

Contacts

Public ContactDu Jie

Xiangya Hospital, Central South University

xiangyadujie@163.com+86 731 8975 3424

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026